Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback